Voriconazole-Induced Periostitis After Allogeneic Stem Cell Transplantation

Clin Nucl Med. 2019 Feb;44(2):159-160. doi: 10.1097/RLU.0000000000002383.

Abstract

A 34-year-old man with history of Hodgkin lymphoma presented 7 months after allogeneic stem cell transplantation with an unexplained severe musculoskeletal pain syndrome. A Tc-MDP bone SPECTCT showed multiple foci with moderate to intense bone uptake across the axial and appendicular skeleton consistent with periostitis. The patient had been on voriconazole daily for 4 months to treat an Aspergillus pneumonia, and in the absence of other causes, a drug-induced periostitis was suspected. Voriconazole was changed to posaconazole with complete resolution of the musculoskeletal symptoms within 3 weeks.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / adverse effects*
  • Hodgkin Disease / therapy
  • Humans
  • Male
  • Periostitis / chemically induced*
  • Periostitis / diagnostic imaging
  • Single Photon Emission Computed Tomography Computed Tomography
  • Stem Cell Transplantation*
  • Voriconazole / adverse effects*

Substances

  • Antifungal Agents
  • Voriconazole